Multicenter, randomized, double blind, phase 3b study to evaluate the safety and efficacy of Benralizumab 30 mg sc in patients with severe asthma uncontrolled on standard of care treatment.
This study is looking at an investigational medication to see how safe it is and how well it works to treat the symptoms of severe and uncontrolled asthma.
Those eligible to participate in this study include:
Interactive Campus Map
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005